Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Total article views   HTML views PDF downloads Totals
16,225 Dovepress* 10,145+ 2,290 12,435
PubMed Central* 6,080 660 6,740
Totals 16,225 2,950 19,175
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar